Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen type VIII alpha 1 chain is a structural extracellular matrix protein encoded by the COL8A1 gene and is one of two alpha chains forming type VIII collagen. It is a major component of the basement membrane of the corneal endothelium and a constituent of vascular endothelia. Type VIII collagen, which can form homo- or heterotrimers, is critical for the structural integrity of specialized basement membranes, especially in the cornea (Descemet’s membrane) and blood vessels. It is necessary for the migration and proliferation of vascular smooth muscle cells, playing a role in vessel wall maintenance and possibly atherogenesis. The C-terminal fragment of the protein, known as Vastatin, exhibits anti-proliferative and pro-apoptotic properties in endothelial cells. Genetic variants in COL8A1 are associated with certain congenital ocular diseases and may contribute to vascular pathologies.
Not a classical pharmacological target; activity involves structural support of basement membranes, modulation of endothelial/smooth muscle cell behavior, and anti-angiogenic activity (Vastatin fragment)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type VIII alpha 1 chain (COL8A1).